What is the present valuation and projected CAGR of the diuretics market?
The diuretics market size has grown steadily in recent years. It will grow from $0.74 billion in 2024 to $0.77 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to prevalence of chronic diseases, aging population, clinical guidelines, pharmaceutical innovation, increase in obesity.
The diuretics market size is expected to see steady growth in the next few years. It will grow to $0.89 billion in 2029 at a compound annual growth rate (CAGR) of 3.5%. The growth in the forecast period can be attributed to rising incidence of hypertension and heart failure, emerging markets, government initiatives, focus on preventive healthcare. Major trends in the forecast period include personalized medicine, innovative drug development, telehealth and remote monitoring, digital health solutions.
Get Your Free Sample of The Global Diuretics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2439&type=smp
What key drivers have fueled the diuretics market’s development over the years?
The increase in renal and kidney disorder cases drives the diuretics market. In such cases, the kidney does not function properly increases the need for water pills (diuretic drugs) to maintain a proper flow of urine. The rise in kidney disorders can be attributed to changes in lifestyle such as the consumption of unhealthy food high in calcium and other minerals. For instance, in May 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based public health agency, an estimated 14% of U.S. adults, or around 35.5 million people, are believed to be living with chronic kidney diseases. Therefore, increase in renal and kidney disorder cases drives the growth of the diuretics market
What is the segmentation for the diuretics market?
The diuretics market covered in this report is segmented –
1) By Type: Osmotic Diuretics, Carbonic Anhydrase Inhibitors, Loop Diuretics, Thiazides And Thiazide-Like Diuretics, Aldosterone Antagonists
2) By Distribution: Hospital Pharmacies, Independent Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies
3) By Application: Hypertension, Glaucoma, Heart Failure, Kidney Stones
Subsegments:
1) By Osmotic Diuretics: Mannitol, Glycerin, Urea
2) By Carbonic Anhydrase Inhibitors: Acetazolamide, Dorzolamide, Brinzolamide
3) By Loop Diuretics: Furosemide, Bumetanide, Torsemide, Ethacrynic Acid
4) By Thiazides And Thiazide-Like Diuretics: Hydrochlorothiazide, Chlorthalidone, Indapamide, Metolazone
5) By Aldosterone Antagonists: Spironolactone, Eplerenone
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/diuretics-drugs-global-market-report
Who are the most influential companies in the diuretics market?
Major companies operating in the diuretics market include Merck & Co. Inc., Meda Manufacturing GmbH, Pfizer Inc., GlaxoSmithKline plc., F. Hoffmann-La Roche AG, Aton Pharma Inc., Boehringer Ingelheim International GmbH, Novartis AG, Teva Pharmaceutical Industries Ltd., Sanofi-aventis U.S. LLC, Centaur Pharmaceuticals Pvt Ltd, Validus Pharmaceuticals LLC, Actavis Generics, Paddock Laboratories LLC, Perrigo Pharmaceutical Company, H. Lundbeck Inc., Oak Pharmaceuticals Inc., Akron Pharmaceuticals Inc., Salix Pharmaceuticals Inc., Alembic Pharmaceuticals Limited, Aurobindo Pharma Limited, IPCA Laboratories Limited, Jubilant Cadista Pharmaceuticals Limited, Mylan N.V., Princeton Laboratories Inc., Sciegen Pharma Limited, Unichem Laboratories Limited, AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, Cipla Ltd, F Hoffmann-La Roche Ltd, Fresenius Kabi AG, Sandoz International GmbH, Sun Pharmaceutical Industries Ltd, Zydus Lifesciences Ltd., Amneal Pharmaceuticals LLC, Apotex Inc.
What are the top industry trends projected to impact the diuretics market?
Major companies operating in the diuretics market are focusing on developing innovative products such as prescription medication to enhance treatment efficacy and reduce side effects for patients with conditions like hypertension and heart failure. Prescription medication refers to drugs that can only be obtained with a doctor’s prescription, ensuring they are used appropriately for specific medical conditions under professional supervision. For instance, in January 2023, Glenmark Pharmaceuticals Limited, an India-based pharmaceutical company, launched a generic version of the diuretic Bumetanide Injection for the treatment of fluid retention and swelling associated with congestive heart failure and other conditions. This product is available in two formulations. 1 mg/4 mL single-dose vials and 2.5 mg/10 mL multi-dose vials, both containing a concentration of 0.25 mg/mL This injection is used to effectively treat edema (fluid retention) caused by conditions such as congestive heart failure, liver disease, and kidney disease, promoting increased urine production to alleviate symptoms like swelling and difficulty breathing.
What are the major regional insights for the diuretics market, and which region holds the top position?
North America was the largest region in the diuretics market in 2023. The Middle East is expected to be the fastest-growing region in the diuretics market during the forecast period. The regions covered in the diuretics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Does The Diuretics Market Report 2025 Offer?
The diuretics market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Diuretic drugs refer to the drugs that help increase the flow of urine by reducing the concentration of sodium and chloride in the body. It helps the body eliminate salt (sodium) and water with these so-called ‘water tablets. Diuretic drugs include diuril, microzide, and indapamide.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2439
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
